In 2023, the myotonic dystrophy treatment market is projected to be worth USD 874.39 million. The global demand for myotonic dystrophy treatment is anticipated to increase at a CAGR of 12.3% between ...

The global isovaleric acidemia treatment market is poised for remarkable growth, projected to rise from USD 652.28 million in 2023 to USD 1,125.15 million by 2033, reflecting a robust CAGR of 5.6%.

The global helicobacter pylori infections treatment market is on a robust growth trajectory, with its value projected to escalate from USD 638.3 million in 2023 to an impressive USD 1,260 million by ...

According to Future Market Insights, myelofibrosis (mf) treatment market is expected to grow at a CAGR of 5.5% between 2023 and 2033, reaching USD 1,280 Million by 2033. The market is expected to ...

Future Market Insights (FMI) has revealed an insightful new report showcasing the remarkable growth trajectory of the global patient monitoring devices market. Valued at USD 46.4 million in 2022, the ...

No refractures were reported during long-term follow-up at five yearsAt 24-months post-implantation, 89% of patients achieved bone unionNovadip plans market launch of NVD003 in 2027Mont Saint-Guibert, ...

The global joint replacement market is poised for steady growth, with revenue expected to increase from USD 20.3 billion in 2025 to USD 32.2 billion by 2035, rising at a CAGR of 4.7% over the forecast ...

The spine pain industry is predicted to be valued at USD 8.03 billion by 2024. The lower back pain market size is estimated to be USD 13.08 billion by 2034, projected at a CAGR of 5%.The surge in the ...